C3 glomerulopathy: consensus report

Détails

Ressource 1Télécharger: 24172683_BIB_D033D6592E29.pdf (1503.65 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_D033D6592E29
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
C3 glomerulopathy: consensus report
Périodique
Kidney Int
Auteur⸱e⸱s
Pickering M. C., D'Agati V. D., Nester C. M., Smith R. J., Haas M., Appel G. B., Alpers C. E., Bajema I. M., Bedrosian C., Braun M., Doyle M., Fakhouri F., Fervenza F. C., Fogo A. B., Fremeaux-Bacchi V., Gale D. P., Goicoechea de Jorge E., Griffin G., Harris C. L., Holers V. M., Johnson S., Lavin P. J., Medjeral-Thomas N., Paul Morgan B., Nast C. C., Noel L. H., Peters D. K., Rodriguez de Cordoba S., Servais A., Sethi S., Song W. C., Tamburini P., Thurman J. M., Zavros M., Cook H. T.
ISSN
1523-1755 (Electronic)
ISSN-L
0085-2538
Statut éditorial
Publié
Date de publication
12/2013
Volume
84
Numéro
6
Pages
1079-89
Langue
anglais
Notes
Pickering, Matthew C
D'Agati, Vivette D
Nester, Carla M
Smith, Richard J
Haas, Mark
Appel, Gerald B
Alpers, Charles E
Bajema, Ingeborg M
Bedrosian, Camille
Braun, Michael
Doyle, Mittie
Fakhouri, Fadi
Fervenza, Fernando C
Fogo, Agnes B
Fremeaux-Bacchi, Veronique
Gale, Daniel P
Goicoechea de Jorge, Elena
Griffin, Gene
Harris, Claire L
Holers, V Michael
Johnson, Sally
Lavin, Peter J
Medjeral-Thomas, Nicholas
Paul Morgan, B
Nast, Cynthia C
Noel, Laure-Helene
Peters, D Keith
Rodriguez de Cordoba, Santiago
Servais, Aude
Sethi, Sanjeev
Song, Wen-Chao
Tamburini, Paul
Thurman, Joshua M
Zavros, Michael
Cook, H Terence
eng
098476/WT_/Wellcome Trust/United Kingdom
G1002528/MRC_/Medical Research Council/United Kingdom
Consensus Development Conference
Research Support, Non-U.S. Gov't
Kidney Int. 2013 Dec;84(6):1079-89. doi: 10.1038/ki.2013.377. Epub 2013 Oct 30.
Résumé
C3 glomerulopathy is a recently introduced pathological entity whose original definition was glomerular pathology characterized by C3 accumulation with absent or scanty immunoglobulin deposition. In August 2012, an invited group of experts (comprising the authors of this document) in renal pathology, nephrology, complement biology, and complement therapeutics met to discuss C3 glomerulopathy in the first C3 Glomerulopathy Meeting. The objectives were to reach a consensus on: the definition of C3 glomerulopathy, appropriate complement investigations that should be performed in these patients, and how complement therapeutics should be explored in the condition. This meeting report represents the current consensus view of the group.
Mots-clé
Biomedical Research, Biopsy, Complement C3/*analysis, Cooperative Behavior, Glomerulonephritis/diagnosis/*immunology/therapy, Humans, International Cooperation, Kidney Glomerulus/*immunology/pathology, Predictive Value of Tests, Prognosis
Pubmed
Création de la notice
01/03/2022 11:18
Dernière modification de la notice
23/11/2022 8:15
Données d'usage